TNF and myeloid sarcoma: In the case of MS, higher serum levels of testosterone may decrease pro-inflammatory cytokines, such as TNF-α and INF-γ, and induce a shift in T helper cell (Th) profile from a Th1-dominant to an Th2-dominant type, while also suppressing lymphocyte proliferation and immunoglobulin production [36].